EUVIMEDEUVIMED entdecken
Crossref

Nano DDS Mediated Angiogenic Cell and Tissue Delivery

Kenichi Nagase

Drug Delivery System · 25.07.2026 · 41 (3) · 194-199

DOI: 10.2745/dds.41.194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery System, erschienen am 25.07.2026. Verfasst von Kenichi Nagase. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocyte sheet transplantation has attracted attention as a novel therapeutic strategy for intractable liver diseases. The authors have developed basic fibroblast growth factor (bFGF)-releasing nanoparticles designed to promote vascularization within transplanted tissues and thereby enhance engraftment efficiency. By utilizing these nanoparticles, transplantation of hepatocyte sheets was successfully achieved. This review outlines the design strategy of the bFGF-containing nanoparticles.

Zitieren

APA

Nagase, K. (2026). Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System, 41(3), 194-199. https://doi.org/10.2745/dds.41.194

Vancouver

Nagase K. Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System. 2026;41(3):194-199. doi:10.2745/dds.41.194

BibTeX
@article{Nagase2026,
  author = {Nagase, Kenichi},
  title = {Nano DDS Mediated Angiogenic Cell and Tissue Delivery},
  journal = {Drug Delivery System},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {194--199},
  doi = {10.2745/dds.41.194}
}
Kostenlos starten →